Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Procaps Group S.A. (NQ: PROC )

1.825 -0.265 (-12.68%)
Streaming Delayed Price Updated: 11:56 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Procaps Group S.A.

< Previous 1 2 3 Next >
5 Value Stocks In The Healthcare Sector
Via Benzinga
Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar
Company to Provide 2023 Value Creation Plan at J.P. Morgan Healthcare Conference 
From Procaps Group, S.A.
Via GlobeNewswire
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
From Procaps Group, S.A.
Via GlobeNewswire
Update on Proposed Acquisition of Grupo Somar
From Procaps Group, S.A.
Via GlobeNewswire
How Does Grupo Somar Acquisition Reaffirms Procaps' Strategy To Strengthen Footprint In LatAm
Via Benzinga
Procaps Group Reports Third Quarter and Nine Months 2022 Results
Constant currency Net Revenues Increased by 15% year-over-year in the 9M22 and by 11% in the 3Q22, signaling a strong demand across our businesses 
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Announces ESG Commitments and Initiatives with Inaugural Report
From Procaps Group, S.A.
Via GlobeNewswire
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Procaps Group to Participate in the BTG Pactual LatAm CEO Conference
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Group Reports Fourth Quarter and Fiscal Year 2021 Financial Results
From Procaps Group S.A.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo... 
Via Benzinga
Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida
From Procaps Group
Via Business Wire
Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director
From Procaps Group
Via Business Wire
Procaps Group Acquires 1st U.S.-Based Softgel Production Facility and Pharmaceutical R&D Center to Expand Global Growth of its iCDMO Business Unit
From Procaps Group
Via Business Wire
Procaps Group Reports Record Third Quarter 2021 Financial Results
From Procaps Group
Via Business Wire
Procaps Group to Host Virtual Investor and Analyst Day on Thursday, August 19, 2021 at 10:00 a.m. Eastern Time
From Union Acquisition Corp. II
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.